Intrathecal baclofen for severe spasticity

G J Hankey, E G Stewart-Wynne, D Perlman

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)


    The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.

    Original languageEnglish
    Pages (from-to)465-6
    Number of pages2
    JournalThe Medical journal of Australia
    Issue number9
    Publication statusPublished - 3 Nov 1986


    Dive into the research topics of 'Intrathecal baclofen for severe spasticity'. Together they form a unique fingerprint.

    Cite this